Aryl hydrocarbon receptor impairs circadian regulation in Alzheimer's disease: Potential impact on glymphatic system dysfunction

Antero Salminen
DOI: https://doi.org/10.1111/ejn.16450
IF: 3.698
2024-06-26
European Journal of Neuroscience
Abstract:Aryl hydrocarbon receptor (AhR) signalling can disturb the circadian‐regulated glymphatic flow and promote AD pathogenesis. Many risk factors for Alzheimer's disease, for example, genetic factors, hypoperfusion, microbiota and many toxins, induce neuroinflammation that stimulates AhR signalling. Subsequently, AhR signalling can impair circadian regulation and disrupt the integrity of the BBB, thus disturbing glymphatic flow and the clearance of β‐amyloid and tau proteins from the brain. Circadian clocks maintain diurnal rhythms of sleep–wake cycle of 24 h that regulate not only the metabolism of an organism but also many other periodical processes. There is substantial evidence that circadian regulation is impaired in Alzheimer's disease. Circadian clocks regulate many properties known to be disturbed in Alzheimer's patients, such as the integrity of the blood–brain barrier (BBB) as well as the diurnal glymphatic flow that controls waste clearance from the brain. Interestingly, an evolutionarily conserved transcription factor, that is, aryl hydrocarbon receptor (AhR), impairs the function of the core clock proteins and thus could disturb diurnal rhythmicity in the BBB. There is abundant evidence that the activation of AhR signalling inhibits the expression of the major core clock proteins, such as the brain and muscle arnt‐like 1 (BMAL1), clock circadian regulator (CLOCK) and period circadian regulator 1 (PER1) in different experimental models. The expression of AhR is robustly increased in the brains of Alzheimer's patients, and protein level is enriched in astrocytes of the BBB. It seems that AhR signalling inhibits glymphatic flow since it is known that (i) activation of AhR impairs the function of the BBB, which is cooperatively interconnected with the glymphatic system in the brain, and (ii) neuroinflammation and dysbiosis of gut microbiota generate potent activators of AhR, which are able to impair glymphatic flow. I will examine current evidence indicating that activation of AhR signalling could disturb circadian functions of the BBB and impair glymphatic flow and thus be involved in the development of Alzheimer's pathology.
neurosciences
What problem does this paper attempt to address?